Beta-Stigmastanol | CAS 19466-47-8 - Request Quote
Beta-Stigmastanol
| SZ CAT No: | SZ-S100003 |
| CAS No | 19466-47-8 |
| Mol.F. | C29H52O |
| Mol.Wt. | 416.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Beta-Stigmastanol is chemically (3S,8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5-ethyl-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-ol. It is also known as Stigmastan-3β-ol. Beta-Stigmastanol is supplied with detailed characterization data compliant with regulatory guideline. Beta-Stigmastanol can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Stigmastanol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 19466-47-8
Purchase 19466-47-8
Order 19466-47-8
Enquire 19466-47-8
price of 19466-47-8
19466-47-8 Supplier
19466-47-8 Manufacturer
19466-47-8 Exporter
buy high quality Beta-Stigmastanol
Purchase Beta-Stigmastanol
Beta-Stigmastanol suppliers
Beta-Stigmastanol manufacturers
Beta-Stigmastanol price
Order Beta-Stigmastanol
Enquire Beta-Stigmastanol
Beta-Stigmastanol cost
Beta-Stigmastanol Supplier
Beta-Stigmastanol Distributor
Beta-Stigmastanol for Method Validation
Stigmastanol Reference Standard
Beta-Stigmastanol for ANDA Filing
Beta-Stigmastanol for Forced Degradation Studies
Beta-Stigmastanol Identification Standards
Beta-Stigmastanol for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.